KneeBRIGHT: Knee Biofeedback Rehabilitation Through Game Therapy

Sponsor
Barron Associates, Inc. (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT06090097
Collaborator
University of North Carolina, Chapel Hill (Other)
60
1
2
11
5.5

Study Details

Study Description

Brief Summary

The goal of this study is to learn about the effect of video-game based rehabilitation exercise for patients with knee osteoarthritis. The main question the study aims to answer is: do patients who exercise with the game have better functional outcomes and engagement compared to patients who do conventional exercise? Participants will complete 10 weeks of physical therapy exercise sessions that focus on quadriceps strengthening. Two sessions per week will be conducted in the clinic, and one session will be conducted at home each week. The interventional group will conduct all exercises using the KneeBRIGHT EMG sensors and game software. The control group will conduct all exercises following a standard physical therapy regimen. Researchers will compare knee function and engagement between the group who uses the game, and the group who does conventional exercise.

Condition or Disease Intervention/Treatment Phase
  • Device: KneeBRIGHT System
  • Other: Control Exercise
N/A

Detailed Description

The KneeBRIGHT game system will be evaluated in a 10-week single-blinded randomized controlled trial. The goals of this study are to: (1) assess improvements in functional outcomes following an exercise regimen conducted by KneeBRIGHT compared to conventional exercise; and (2) evaluate patient engagement during unsupervised, home-based exercises with and without the KneeBRIGHT software. Over the course of the study period, the knee OA participants will conduct physical therapy sessions with the physical therapist (PT) who enrolled them. The exercise regimen will implement each PT's standard of care, consisting of two weekly clinic sessions and one weekly home exercise session, for 10 weeks. Knee OA participants will be randomly assigned (via block randomization for each PT) to use either the KneeBRIGHT system for both clinic and home exercise, or to receive standard care with conventional exercise routines. Participants will conduct functional exercise assessments on study intake and again on study completion. Participants will also complete questionnaires focused on exercise engagement on study completion.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
randomized control trialrandomized control trial
Masking:
Single (Outcomes Assessor)
Masking Description:
Researchers conducting functional outcomes on study completion will be blinded from the intervention group.
Primary Purpose:
Treatment
Official Title:
Knee-Biofeedback Rehabilitation Interface for Game-based Home Therapy
Anticipated Study Start Date :
Jan 1, 2024
Anticipated Primary Completion Date :
Nov 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: KneeBRIGHT Group

The interventional group will conduct all exercises during the 10-week therapy regimen using the KneeBRIGHT electromyogram sensors and game software.

Device: KneeBRIGHT System
The KneeBRIGHT system includes electromyogram sensors and video game software that leads participants through physical therapy exercise.

Active Comparator: Control Group

The control group will conduct all exercises following a standard physical therapy regimen.

Other: Control Exercise
The control group will complete a 10-week regimen of conventional PT exercise

Outcome Measures

Primary Outcome Measures

  1. Knee Osteoarthritis Outcome Score [After 10 weeks (study completion)]

    A multi-dimensional assessment that classifies knee outcomes into five categories: pain, symptoms, activities of daily living (ADL), sport, and quality of life

  2. Timed get-up-and-go score [After 10 weeks (study completion)]

    In the timed up and go (TUG) test, subjects are asked to rise from a standard armchair, walk to a marker 3 m away, turn, walk back, and sit down again.

  3. 6-minute walk test [After 10 weeks (study completion)]

    The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface.

  4. Quadriceps strength [After 10 weeks (study completion)]

    Quadriceps strength will be measured by recording isokinetic knee extension torque as measured by a dynamometer

  5. Patient Activation Model Scores [After 10 weeks (study completion)]

    The Patient Activation Model (PAM) is an established, highly reliable, questionnaire that reflects a developmental model of patient engagement with their healthcare regimens

Secondary Outcome Measures

  1. Patient technology acceptance [After 10 weeks (study completion)]

    Participants will complete a questionnaire, designed based on the established Technology Acceptance Model to assess their level of technology acceptance.

Other Outcome Measures

  1. Patient home exercise adherence [After 10 weeks (study completion)]

    The KneeBRIGHT software will log the exercises completed at home; these logs will report number of exercises conducted, level of resistance, and timestamps for the sessions. Control group participants will log home exercises using a written checklist of exercises

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • diagnosis via x-ray, with a score of at least 2 (out of 4) on the Kellgren-Lawrence OA scoring system; independent ambulation without assistive device
Exclusion Criteria:
  • individuals who have psychiatric or cognitive impairment (e.g., dementia) that interferes with their ability to follow instructions or provide voluntary consent; symptomatic spine, hip, ankle, or foot disease other than OA that would interfere with assessment of the knee.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of North Carolina Chapel Hill Chapel Hill North Carolina United States 27599

Sponsors and Collaborators

  • Barron Associates, Inc.
  • University of North Carolina, Chapel Hill

Investigators

  • Principal Investigator: Eileen Krepkovich, MS, Barron Associates

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Barron Associates, Inc.
ClinicalTrials.gov Identifier:
NCT06090097
Other Study ID Numbers:
  • KneeBRIGHT2B
First Posted:
Oct 19, 2023
Last Update Posted:
Oct 19, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Barron Associates, Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 19, 2023